Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Article
Nature 445, 437-441 (7 January 2007) | doi:10.1038/nature05474;
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
- More Challenges
- Powered by:
nature jobs
Tenure-Stream Position in Oral Microbiology
- University of Toronto
- Toronto, ON Canada
Organic Chemistry
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
Oncogenic tyrosine kinases have proved to be promising targets for the development of highly effective anticancer drugs. However, tyrosine kinase inhibitors (TKIs) against the human epidermal growth factor receptor (HER) family show only limited activity against HER2-driven breast cancers, despite effective inhibition of epidermal growth factor receptor (EGFR) and HER2 in vivo.
&
Abstract
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
